definiens: means this Supply Agreement Sale and Assignment agreement ; ( b ) means the rights, entitlements, and obli gations under i ) the Agreement on Sale and Purchase of Dossier For Paclitaxel dated February 22, 2013 between AqVida GmbH and Assignor, a copy of which is attached Exhibit A, ii ) t he Agreement on Sale and Purchase of Dossier For Oxaliplatin dated March 28, 2013 between AqVida GmbH and Assignor, a copy of which is attached Exhibit A, iii ) the Agreement on Sale and Purchase of Dossier For Docetaxel dated June 6, 2013 between AqVida GmbH and Assignor, a copy of which is attached Exhibit A, iv ) the Principal Agreement dated March 20, 2013 between Neogen Developments N.V. and Assignor, a copy of which is attached Exhibit A, and v ) the Service Agreement dated June 11, 2013 between the Ass ignor and World Medical Care GmbH & Co. KG, and any amendments to the se agreements constituting the Assets and any proprietary technologies of the Assignor, whether incorporating, utilizing, or based on the Assets or otherwise, including, without limitati on all information and work product related to, connected with, and/or ancillary to such Assets that was created, invented, developed, conceived, or reduced to practice by the Assignor ’s employees and contractors, including, without limitation, all inventi ons, concepts, formulae, database s, know -how, trade secrets, methods, processes, data files, doc umentation, sales data, clinical data, test data, trial data, flow charts, diagrams, other documentation and reasonably related notes, comments, and memoranda, physical media containing any of the foregoing, and all versions thereof, whether stored, encoded, recorded, or written on any type of media ; ( c ) means all revenues to the Assignee derived from an y combination of Net Sales and sublicensing r evenue from exploitation and sale of the Products relating to the Assets, excluding equity purchases of the Assignee ’s securities ; ( d ) means the date that the shares of the Assignee are approved for trading on the Canadian Securities Exchange ( ) ; ( e ) means all gross revenues derived by the Assingee through the sale, use, or commercialization of the Products by i tself, its Affiliates, and any authorized s ubAssignee s, less ( i ) all trade, quantity, and cash discounts actually allowed on the Products, ( ii ) all credits and allowances actually granted on Products on account of rejection, returns, billing errors, and retroactive price reductions, ( iii ) dutie s actually paid on the Products, and ( iv ) excise, sale and use taxes, and equivalent taxes actually paid on the Products ; and ( f ) means any product, method, process, device, or services that is developed, made, use, sold, distributed, imported or exported by utilizing or incorporating in any way, whether directly or indirectly, any Assets